| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.19 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |